Rights Issue Committee approves LOF, ALOF and CAF for Indrayani Biotech's upcoming rights issue, enabling the renunciation process and investor communications.
AI Assistant
Indrayani Biotech Ltd
2026
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.